Matches in Wikidata for { <http://www.wikidata.org/entity/Q98300874> ?p ?o ?g. }
- Q98300874 description "2020 nî lūn-bûn" @default.
- Q98300874 description "2020 թվականի օգոստոսի 10-ին հրատարակված գիտական հոդված" @default.
- Q98300874 description "2020年の論文" @default.
- Q98300874 description "2020年学术文章" @default.
- Q98300874 description "2020年学术文章" @default.
- Q98300874 description "2020年学术文章" @default.
- Q98300874 description "2020年学术文章" @default.
- Q98300874 description "2020年学术文章" @default.
- Q98300874 description "2020年学术文章" @default.
- Q98300874 description "2020年學術文章" @default.
- Q98300874 description "2020年學術文章" @default.
- Q98300874 description "2020年學術文章" @default.
- Q98300874 description "2020年學術文章" @default.
- Q98300874 description "2020年學術文章" @default.
- Q98300874 description "2020년 논문" @default.
- Q98300874 description "article científic" @default.
- Q98300874 description "article scientific" @default.
- Q98300874 description "article scientifique" @default.
- Q98300874 description "articol științific" @default.
- Q98300874 description "articolo scientifico" @default.
- Q98300874 description "artigo científico" @default.
- Q98300874 description "artigo científico" @default.
- Q98300874 description "artigo científico" @default.
- Q98300874 description "artikel ilmiah" @default.
- Q98300874 description "artikull shkencor" @default.
- Q98300874 description "artikulong pang-agham" @default.
- Q98300874 description "artykuł naukowy" @default.
- Q98300874 description "artículo científico publicado en 2020" @default.
- Q98300874 description "artículu científicu" @default.
- Q98300874 description "bilimsel makale" @default.
- Q98300874 description "bài báo khoa học" @default.
- Q98300874 description "naučni članak" @default.
- Q98300874 description "scienca artikolo" @default.
- Q98300874 description "scientific article published on 10 August 2020" @default.
- Q98300874 description "scientific article published on 10 August 2020" @default.
- Q98300874 description "scientific article published on 10 August 2020" @default.
- Q98300874 description "teaduslik artikkel" @default.
- Q98300874 description "tieteellinen artikkeli" @default.
- Q98300874 description "tudományos cikk" @default.
- Q98300874 description "vedecký článok" @default.
- Q98300874 description "vetenskaplig artikel" @default.
- Q98300874 description "videnskabelig artikel udgivet 10. august 2020" @default.
- Q98300874 description "vitenskapelig artikkel" @default.
- Q98300874 description "vitskapeleg artikkel" @default.
- Q98300874 description "vědecký článek" @default.
- Q98300874 description "wetenschappelijk artikel" @default.
- Q98300874 description "wissenschaftlicher Artikel" @default.
- Q98300874 description "επιστημονικό άρθρο" @default.
- Q98300874 description "мақолаи илмӣ" @default.
- Q98300874 description "наукова стаття, опублікована в серпні 2020" @default.
- Q98300874 description "научна статия" @default.
- Q98300874 description "научная статья" @default.
- Q98300874 description "научни чланак" @default.
- Q98300874 description "научни чланак" @default.
- Q98300874 description "מאמר מדעי" @default.
- Q98300874 description "مقالة علمية نشرت في 10 أغسطس 2020" @default.
- Q98300874 description "১০ আগস্ট ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q98300874 description "บทความทางวิทยาศาสตร์" @default.
- Q98300874 description "სამეცნიერო სტატია" @default.
- Q98300874 name "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or st" @default.
- Q98300874 name "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or st" @default.
- Q98300874 type Item @default.
- Q98300874 label "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or st" @default.
- Q98300874 label "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or st" @default.
- Q98300874 prefLabel "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or st" @default.
- Q98300874 prefLabel "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or st" @default.
- Q98300874 P1433 Q98300874-F8579CCB-F3E3-462C-A790-8A082887834B @default.
- Q98300874 P1476 Q98300874-4752E615-BC89-40E4-AE88-BA5BB2F05E27 @default.
- Q98300874 P2093 Q98300874-06B51D8D-7449-43D0-BA91-39928D22E43B @default.
- Q98300874 P2093 Q98300874-164DB0E5-2A08-4AEA-8A7D-F1BB886E4F9C @default.
- Q98300874 P2093 Q98300874-6AD890E4-5DA5-4A00-9FA5-539BA79BCD40 @default.
- Q98300874 P2093 Q98300874-7C052F25-F737-4FFC-8767-6B7847D9B891 @default.
- Q98300874 P2093 Q98300874-8439A35B-74C7-4814-804D-2ED632C55438 @default.
- Q98300874 P2093 Q98300874-E7E7B1C8-6C56-45A0-AC2D-F7ABF56FA24A @default.
- Q98300874 P304 Q98300874-BCCF5984-B1E8-4D92-943D-6003652C948D @default.
- Q98300874 P31 Q98300874-0A8357CD-39E7-4E46-8199-DBFD0E3FF849 @default.
- Q98300874 P356 Q98300874-F77F46B3-3C22-4BBC-9647-ACEFC24D3440 @default.
- Q98300874 P433 Q98300874-A2B8E739-5DD6-413B-B101-6449C11838A3 @default.
- Q98300874 P478 Q98300874-85CCF993-D7A6-4585-8451-398A75DEE186 @default.
- Q98300874 P50 Q98300874-1C5868D5-A012-4D6B-8044-5796EAB095F6 @default.
- Q98300874 P577 Q98300874-6E95AC02-0CED-43B4-BCE6-F7ADABB6E758 @default.
- Q98300874 P698 Q98300874-27E487E9-82B6-426E-A2C1-3BED72CB2875 @default.
- Q98300874 P921 Q98300874-51ACDA76-4F6D-42E3-A192-C9308E500B46 @default.
- Q98300874 P921 Q98300874-B3D0BD15-0D62-4BAC-8855-F38B9B9C0CD6 @default.
- Q98300874 P356 S12885-020-07253-X @default.
- Q98300874 P698 32778095 @default.
- Q98300874 P1433 Q326300 @default.
- Q98300874 P1476 "Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment" @default.
- Q98300874 P2093 "Aurélie Bertaut" @default.
- Q98300874 P2093 "Caroline Truntzer" @default.
- Q98300874 P2093 "Emeric Limagne" @default.
- Q98300874 P2093 "Emilie Rederstorff" @default.
- Q98300874 P2093 "Francois Ghiringhelli" @default.
- Q98300874 P2093 "Marion Thibaudin" @default.
- Q98300874 P304 "748" @default.
- Q98300874 P31 Q13442814 @default.
- Q98300874 P356 "10.1186/S12885-020-07253-X" @default.
- Q98300874 P433 "1" @default.
- Q98300874 P478 "20" @default.
- Q98300874 P50 Q91044128 @default.